Published in J Exp Med on October 01, 1990
Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med (1994) 1.83
Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev (2008) 1.64
Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci U S A (1991) 1.61
Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci U S A (1996) 1.52
Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun (1992) 1.52
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J Clin Invest (1992) 1.39
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infect Immun (1996) 1.20
Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect Immun (1999) 1.17
Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci U S A (1994) 1.16
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS One (2012) 1.16
Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Parasite Immunol (2007) 1.14
Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect Immun (1993) 1.14
Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect Immun (1999) 1.12
Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proc Natl Acad Sci U S A (1994) 1.09
Bacteria as vectors for gene therapy of cancer. Bioeng Bugs (2011) 1.05
Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium. Infect Immun (1994) 1.03
Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect Immun (1996) 1.03
Malaria vaccine development. Clin Microbiol Rev (1994) 1.01
Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections. Philos Trans R Soc Lond B Biol Sci (1997) 1.00
Tracking the dynamics of salmonella specific T cell responses. Curr Top Microbiol Immunol (2009) 0.99
Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle. Infect Immun (2000) 0.97
Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium. Infect Immun (1994) 0.97
Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology (1994) 0.95
Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect Immun (1995) 0.95
Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes. Infect Immun (2002) 0.91
Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes. Infect Immun (1992) 0.90
Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy. Infect Immun (2007) 0.89
Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Vaccine (2011) 0.88
Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production. Infect Immun (2002) 0.88
Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology (1994) 0.85
An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth. Cancer Gene Ther (2009) 0.84
Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium. Infect Immun (1996) 0.83
The cytotoxic T-lymphocyte epitope of the Plasmodium falciparum circumsporozoite protein also modulates the efficiency of receptor-ligand interaction with hepatocytes. Infect Immun (2000) 0.83
Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles. Immunology (1996) 0.82
Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity. Immunology (1994) 0.80
Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant. Infect Immun (1993) 0.79
Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Immunology (1998) 0.79
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. Open Virol J (2013) 0.79
Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase. Infect Immun (2000) 0.79
Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses. Clin Rheumatol (1996) 0.77
Major histocompatibility complex class I peptide presentation after Salmonella enterica serovar typhimurium infection assessed via stable isotope tagging of the B27-presented peptide repertoire. Infect Immun (2004) 0.77
HIV Vaccine Strategies - an Update. Med J Armed Forces India (2011) 0.75
Role of circumsporozoite protein-specific T-cells in protective immunity against Plasmodium berghei. Bull World Health Organ (1990) 0.75
Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E. Sci Rep (2017) 0.75
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A (1972) 57.06
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (1981) 19.90
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell (1986) 14.96
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A (1988) 4.67
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (1989) 4.08
Transduction of virulence within the species Salmonella typhimurium. J Gen Microbiol (1956) 4.05
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest (1987) 3.03
Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol (1989) 2.64
Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies. J Exp Med (1979) 2.58
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature (1988) 2.56
Research toward malaria vaccines. Science (1986) 2.40
Interaction between Salmonella typhimurium and phagocytic cells in cell culture. J Infect Dis (1959) 2.19
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science (1987) 2.17
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science (1988) 2.09
Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science (1989) 2.09
Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose. J Immunol Methods (1985) 1.93
Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun (1987) 1.87
Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77
Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev (1980) 1.76
Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol Biochem Parasitol (1985) 1.70
Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev Biol Stand (1983) 1.64
A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. Microb Pathog (1988) 1.54
Development of a sporozoite malaria vaccine. Am J Trop Med Hyg (1986) 1.30
Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol (1985) 1.15
Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines. Infect Immun (1983) 1.05
Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. J Immunol (1988) 0.91
The optimization principle in phylogenetic analysis tends to give incorrect topologies when the number of nucleotides or amino acids used is small. Proc Natl Acad Sci U S A (1998) 15.43
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
A new method of inference of ancestral nucleotide and amino acid sequences. Genetics (1995) 10.23
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
HhaI methyltransferase flips its target base out of the DNA helix. Cell (1994) 8.72
Incomplete taxon sampling is not a problem for phylogenetic inference. Proc Natl Acad Sci U S A (2001) 8.53
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol (2000) 7.77
Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development (1996) 7.00
Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. Nucleic Acids Res (1993) 6.15
The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A (1997) 6.08
Human leukocyte interferon produced by E. coli is biologically active. Nature (1980) 5.86
Genetic analysis of an E. coli strain with a mutation affecting DNA polymerase. Nature (1969) 5.10
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Strong coupling of a single photon to a superconducting qubit using circuit quantum electrodynamics. Nature (2004) 4.54
The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature (1981) 4.50
Continental breakup and the ordinal diversification of birds and mammals. Nature (1996) 4.44
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood (2001) 4.22
Folding funnels, binding funnels, and protein function. Protein Sci (1999) 4.22
Crystal structure of the HhaI DNA methyltransferase complexed with S-adenosyl-L-methionine. Cell (1993) 3.96
Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet (2001) 3.95
Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc Natl Acad Sci U S A (1978) 3.84
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol (1997) 3.83
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med (1990) 3.80
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet (2000) 3.73
Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1. Proc Natl Acad Sci U S A (1995) 3.68
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell (2000) 3.39
Angiogenesis induced by degradation products of hyaluronic acid. Science (1985) 3.37
p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell (1998) 3.27
Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science (1991) 3.27
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Folding funnels and binding mechanisms. Protein Eng (1999) 3.25
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Complete amino acid sequence of the catalytic subunit of bovine cardiac muscle cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1981) 3.07
Divergence time estimates for the early history of animal phyla and the origin of plants, animals and fungi. Proc Biol Sci (1999) 3.04
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Role of angiogenesis in patients with cerebral ischemic stroke. Stroke (1994) 2.96
Tobacco promotion and susceptibility to tobacco use among adolescents aged 12 through 17 years in a nationally representative sample. Am J Public Health (1996) 2.95
Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. JAMA (1987) 2.84
Amino acid sequence of human von Willebrand factor. Biochemistry (1986) 2.73
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. J Clin Invest (1992) 2.66
A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62
Molecular cloning and nucleotide sequence of the type I beta-lactamase gene from Bacillus cereus. Nucleic Acids Res (1983) 2.61
Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. Genes Dev (1997) 2.60
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55
Prognostic impact of lymphadenectomy in uterine serous cancer. BJOG (2012) 2.54
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS (1998) 2.53
Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line. Cell (1979) 2.50
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J Virol (1997) 2.47
Does nonneutral evolution shape observed patterns of DNA variation in animal mitochondrial genomes? Annu Rev Genet (2001) 2.46
Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet (1987) 2.44
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science (1985) 2.44
Human origins and analysis of mitochondrial DNA sequences. Science (1992) 2.43
Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci U S A (1989) 2.40
Prevalence of dementia in a rural setting: A report from India. Int J Geriatr Psychiatry (1997) 2.39
Does central obesity reflect "Cushing's disease of the omentum"? Lancet (1997) 2.34
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009) 2.33
Entactin, a novel basal lamina-associated sulfated glycoprotein. J Biol Chem (1981) 2.32
Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (1997) 2.32
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma. Leukemia (2009) 2.28
Properties of adenyl cyclase and cyclic adenosine 3',5'-monophosphate receptor protein-deficient mutants of Escherichia coli. J Bacteriol (1976) 2.27
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coli. Protein Expr Purif (1999) 2.24
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet (2008) 2.21
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int (2008) 2.21
Orthostatic hypotension in Parkinson's disease. Lancet (1972) 2.19
Detection of convergent and parallel evolution at the amino acid sequence level. Mol Biol Evol (1997) 2.15
A modified protocol for rapid DNA isolation from plant tissues using cetyltrimethylammonium bromide. Nat Protoc (2006) 2.14
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J (2000) 2.13
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology (2000) 2.12
Water supplementation in exclusively breastfed infants during summer in the tropics. Lancet (1991) 2.09
Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood (2000) 2.09
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med (1990) 2.09
Treatment of acute polyneuropathy by plasma exchange. Lancet (1978) 2.06
On appetite and its loss. J Clin Oncol (2000) 2.06
Cell death by autophagy: facts and apparent artefacts. Cell Death Differ (2011) 2.06
Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics (1986) 2.04
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions. Trends Cell Biol (1999) 2.03
Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia (2006) 2.02
Thalidomide as initial therapy for early-stage myeloma. Leukemia (2003) 2.02
Additional evidence that the hemin-controlled translational repressor from rabbit reticulocytes is a protein kinase. Biochem Biophys Res Commun (1977) 2.01
Complete amino acid sequence of rabbit muscle glycogen phosphorylase. Proc Natl Acad Sci U S A (1977) 2.00
Spontaneous pneumothorax and mitral valve prolapse. Chest (1986) 1.99
Human fibroblast interferon gene lacks introns. Nucleic Acids Res (1981) 1.98
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J (1996) 1.97